CALCULATE YOUR SIP RETURNS

Sigachi Industries Invests $1 Million in Hyderabad R&D Centre to Boost API Development

Written by: Team Angel OneUpdated on: Feb 4, 2025, 3:34 PM IST
Sigachi Industries invests $1 million in a Hyderabad R&D centre, enhancing API development and analytical capabilities under one roof.
Sigachi Industries Invests $1 Million in Hyderabad R&D Centre to Boost API Development
ShareShare on 1Share on 2Share on 3Share on 4Share on 5

Sigachi Industries Limited, a key player in the pharmaceutical industry, has announced a significant step towards innovation with the establishment of a state-of-the-art Research and Development (R&D) facility in Hyderabad, India. This strategic initiative, backed by an investment of up to $1 million, aims to streamline its Active Pharmaceutical Ingredients (API) development and analytical research efforts, reinforcing the company’s commitment to excellence and long-term growth. Share price of Sigachi Industries jumps over 3% as 12:06 PM on February 4, 2025. 

Strengthening the API Development Pipeline

Sigachi’s new R&D centre will focus on optimising API production by integrating cutting-edge systems while adhering to stringent global regulatory standards. The investment is expected to accelerate the company’s development pipeline and support the expansion of six Certificate of Suitability to the Monographs of the European Pharmacopoeia (CEP) filings over the next six months.

The facility is designed to:

  • Optimise API production by ensuring high-quality outputs that meet international standards.
  • Expand R&D capabilities with a dedicated USD 1 million investment.
  • Employ 15-20 skilled scientists to enhance product development for regulated markets.
  • Streamline pharmaceutical product portfolio, focusing on high-priority APIs and intermediates.
  • Create synergies for manufacturing and regulatory filings, consolidating operations under one roof.

A Commitment to Innovation and Growth

Commenting on this initiative, Amit Raj Sinha, Managing Director and CEO of Sigachi Industries, highlighted the company’s growing focus on R&D.

“We have made significant progress in delivering APIs to the pharmaceutical market. Our increased commitment to R&D is a clear testament to our strategic vision for innovation and excellence. By deepening our investments, we aim to accelerate our development efforts while reinforcing our long-term growth objectives and strengthening Sigachi’s overall pipeline.”

About Sigachi Industries

With over 35 years of experience, Sigachi Industries Limited is a leading player in the pharmaceutical sector, specialising in APIs, intermediates, excipients, and vitamin-mineral nutrient blends. The company operates 5 manufacturing facilities across Telangana, Gujarat, and Karnataka, with a global presence spanning 65+ countries.

Sigachi continues to invest in research and technology to develop high-value pharmaceutical solutions, ensuring stringent compliance with international safety and quality standards. Its commitment to innovation has positioned it as a trusted partner for pharmaceutical and nutraceutical companies worldwide.

Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation/investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions. 

Investments in the securities market are subject to market risks, read all the related documents carefully before investing

Published on: Feb 4, 2025, 3:34 PM IST

Team Angel One

Team Angel One is a group of experienced financial writers that deliver insightful articles on the stock market, IPO, economy, personal finance, commodities and related categories.

Know More

We're Live on WhatsApp! Join our channel for market insights & updates

Open Free Demat Account!

Join our 2.5 Cr+ happy customers

+91
Enjoy Zero Brokerage on Equity Delivery
4.4 Cr+DOWNLOADS
Enjoy ₹0 Account Opening Charges

Get the link to download the App

Get it on Google PlayDownload on the App Store
Open Free Demat Account!
Join our 2.5 Cr+ happy customers